Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.

Sheline YI, Morris JC, Snyder AZ, Price JL, Yan Z, D'Angelo G, Liu C, Dixit S, Benzinger T, Fagan A, Goate A, Mintun MA.

J Neurosci. 2010 Dec 15;30(50):17035-40. doi: 10.1523/JNEUROSCI.3987-10.2010.

2.

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.

Chételat G, Fouquet M.

Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6. Review.

3.

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Fouquet M, Besson FL, Gonneaud J, La Joie R, Chételat G.

Neuropsychol Rev. 2014 Sep;24(3):290-9. doi: 10.1007/s11065-014-9263-8. Epub 2014 Aug 22. Review.

PMID:
25146994
4.

Functional brain connectivity using fMRI in aging and Alzheimer's disease.

Dennis EL, Thompson PM.

Neuropsychol Rev. 2014 Mar;24(1):49-62. doi: 10.1007/s11065-014-9249-6. Epub 2014 Feb 23. Review.

5.

Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.

Chételat G, La Joie R, Villain N, Perrotin A, de La Sayette V, Eustache F, Vandenberghe R.

Neuroimage Clin. 2013 Mar 5;2:356-65. doi: 10.1016/j.nicl.2013.02.006. eCollection 2013. Review.

6.

Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development.

Oriá RB, Patrick PD, Blackman JA, Lima AA, Guerrant RL.

Med Hypotheses. 2007;68(5):1099-107. Epub 2006 Nov 13. Review.

Supplemental Content

Support Center